Similar Items: Mechanistic synergies and optimal sequencing of anti‑VEGF plus immune checkpoint inhibition in gastrointestinal cancers
- Clinical outcomes of immune checkpoint inhibitor based therapy in NRG1 fusion positive non small cell lung cancer a retrospective study
- Peripheral blood IFN-γ–producing T-cell subsets and soluble IL-2 receptor as independent prognostic biomarkers in NSCLC treated with immune checkpoint inhibitor–based therapy
- KLF14 inhibits EMT in esophageal cancer cells through inhibition of the MISP-Wnt/β-catenin signaling axis
- Early kinetics of CA19-9 and CEA after 5-FU-based chemotherapy for gastrointestinal cancers
- Immune subtyping of colorectal adenoma identifies a subtype with activated adaptive immunity ahead of progressing to cancer
- Ferroptosis-related gene EPAS1 suppresses breast cancer progression by inhibiting M2 macrophage polarization